CVS Health Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss decreased by 52.8% to $25.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 257.1%, from $7.00M to $25.00M. Over 4 years (FY 2020 to FY 2024), Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss shows an upward trend with a 88.8% CAGR.
other_debt_securities_available_for_sale_continuous_unre_d33b47| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $31.00M | $49.00M | $84.00M | $623.00M | $1.37B | $1.79B | $1.23B | $288.00M | $229.00M | $234.00M | $28.00M | $47.00M | $64.00M | $7.00M | $127.00M | $71.00M | $53.00M | $25.00M |
| QoQ Change | — | +58.1% | +71.4% | +641.7% | +119.4% | +30.7% | -31.4% | -76.5% | -20.5% | +2.2% | -88.0% | +67.9% | +36.2% | -89.1% | >999% | -44.1% | -25.4% | -52.8% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | -53.8% | -83.2% | -86.9% | -97.7% | -83.7% | -72.1% | -97.0% | +353.6% | +51.1% | -17.2% | +257.1% |